Lord, Abbett & Co
PRAH

Lord, Abbett & Co’s PRA Health Sciences, Inc. PRAH Stock Holding History

Lord, Abbett & Co’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-144,979
Closed -$13.3M – 817
2018
Q4 		$13.3M Sell
144,979
-15,240
-10% -$1.54M 0.05% 481
2018
Q3 		$17.7M Buy
+160,219
New +$16.7M 0.05% 505

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Lord, Abbett & Co's PRAH Position: Q1 2019 in Review

Lord, Abbett & Co sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2019, closing a stake of 144,979 shares — an estimated $13.3M sold.

Lord, Abbett & Co first reported a position in PRAH in Q3 2018 and held it in 2 quarters. The position peaked at $17.7M in Q3 2018. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

  • Lord, Abbett & Co reported no remaining PRA Health Sciences, Inc. position as of Q1 2019 after selling out during the quarter.
  • Lord, Abbett & Co sold 144,979 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $13.3M.
  • Lord, Abbett & Co first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 2 quarters.
  • Lord, Abbett & Co's PRA Health Sciences, Inc. position peaked at $17.7M in Q3 2018.
  • 354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on Lord, Abbett & Co's 13F filing for Q1 2019, filed 15 May 2019.